JP Morgan Chase & Co’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.15M | Buy |
|
|||||
|
2025
Q2 | $7.27M | Buy |
|
|||||
|
2025
Q1 | $888K | Sell |
|
|||||
|
2024
Q4 | $12.4M | Buy |
|
|||||
|
2024
Q3 | $585K | Sell |
|
|||||
|
2024
Q2 | $794K | Buy |
|
|||||
|
2024
Q1 | $772K | Sell |
|
|||||
|
2023
Q4 | $750K | Buy |
|
|||||
|
2023
Q3 | $391K | Sell |
|
|||||
|
2023
Q2 | $427K | Buy |
|
|||||
|
2023
Q1 | $393K | Sell |
|
|||||
|
2022
Q4 | $527K | Sell |
|
|||||
|
2022
Q3 | $483K | Sell |
|
|||||
|
2022
Q2 | $567K | Sell |
|
|||||
|
2022
Q1 | $628K | Buy |
|
|||||
|
2021
Q4 | $436K | Buy |
|
|||||
|
2021
Q3 | $362K | Buy |
|
|||||
|
2021
Q2 | $366K | Sell |
|
|||||
|
2021
Q1 | $351K | Sell |
|
|||||
|
2020
Q4 | $415K | Buy |
|
|||||
|
2020
Q3 | $326K | Sell |
|
|||||
|
2020
Q2 | $508K | Sell |
|
|||||
|
2020
Q1 | $463K | Sell |
|
|||||
|
2019
Q4 | $582K | Sell |
|
|||||
|
2019
Q3 | $680K | Buy |
|
|||||
|
2019
Q2 | $620K | Sell |
|
|||||
|
2019
Q1 | $635K | Sell |
|
|||||
|
2018
Q4 | $954K | Sell |
|
|||||
|
2018
Q3 | $1.27M | Buy |
|
|||||
|
2018
Q2 | $1.12M | Sell |
|
|||||
|
2018
Q1 | $1.14M | Buy |
|
|||||
|
2017
Q4 | $1.09M | Sell |
|
|||||
|
2017
Q3 | $1.14M | Sell |
|
|||||
|
2017
Q2 | $1.16M | Sell |
|
|||||
|
2017
Q1 | $1.36M | Buy |
|
|||||
|
2016
Q4 | $1.1M | Buy |
|
|||||
|
2016
Q3 | $1.01M | Sell |
|
|||||
|
2016
Q2 | $1.23M | Sell |
|
|||||
|
2016
Q1 | $1.59M | Buy |
|
|||||
|
2015
Q4 | $1.2M | Sell |
|
|||||
|
2015
Q3 | $1.3M | Buy |
|
|||||
|
2015
Q2 | $1.35M | Sell |
|
|||||
|
2015
Q1 | $1.38M | Buy |
|
|||||
|
2014
Q4 | $810K | Buy |
|
|||||
|
2014
Q3 | $425K | Buy |
|
|||||
|
2014
Q2 | $403K | Sell |
|
|||||
|
2014
Q1 | $600K | Buy |
|